Advertisement
Constitution Medical Investors will focus on the identification andacquisition of innovative, healthcare-related platform technologies andcompanies where the principals will be able to leverage their productdevelopment, regulatory, clinical and commercial experience. Over the courseof 15 years at Cytyc, one of the leading companies focused on improvinghealthcare for women, the CMI executive team helped grow the company toapproximately $700 million in annual revenues and establish operations in 20countries.
Advertisement
"Having helped to build Cytyc Corporation to its preeminent position inwomen's health, and with the integration of Cytyc with Hologic now complete,we are excited to put our extensive experience to work in a new venture," saidMr. Sullivan. "We are proud of our track record of success in creating valuein the healthcare marketplace, and we are very pleased to partner with WarburgPincus, which will provide us with world-class support and resources that willallow us to once again make a real difference in improving medical care."
"Pat and I have enjoyed a symbiotic business relationship for more than 20years. I can't think of a partnership with more potential than what we haveformed with CMI," said Mr. Levangie.
Bess Weatherman, the Warburg Pincus Managing Director who leads the firm'sinvestment activities in medical devices and healthcare services, said, "Weare very excited to join Pat and Dan in the formation of CMI, and are eager towork with them in the identification of opportunities that will leverage theirdeep experience and industry know-how."
Constitution Medical Investors is based in Boston, MA at: BostonIndependence Wharf, 470 Atlantic Avenue, 4th Floor. Boston, MA 02210.617-273-8418.
About Constitution Medical Investors, Inc.
Constitution Medical Investors, Inc. is a Boston-based private investmentfirm focused on healthcare sector-related acquisitions, and launched inpartnership with Warburg Pincus, the global private equity firm. CMI is ledby Patrick Sullivan, formerly President and Chief Executive Officer of CytycCorporation and Executive Chairman of Hologic, Inc. (Nasdaq: HOLX), and DanielLevangie, formerly Executive Vice President of Cytyc Corporation and Presidentof Cytyc's Surgical Products Division. CMI focuses on the identification andacquisition of innovative, healthcare-related platform technologies andcompanies where the principals will be able to leverage their productdevelopment, regulatory, clinical and commercial experience. For moreinformation, visit www.conmedinvestors.com.
About Warburg Pincus
Warburg Pincus has been a leading private equity investor since 1971. Thefirm currently has more than $35 billion of assets under management. WarburgPincus' investments are focused on a range of sectors in North America, Europeand Asia, including financial services, healthcare, industrial, technology,media and telecommunications, energy, consumer and retail and real estate.Since inception, the firm has raised 12 private equity funds that haveinvested more than $31 billion in approximately 600 companies in more than 30countries. The firm has invested $6.6 billion i
